Productos farmacéuticos y dispositivos médicos

Featured news

Other news

“Better treatment for better health: lifting the veil on treatment optimisation” – Stakeholders exchange views on patient-centred clinical research at EORTC and AIM’s seminar

Treatment optimisation is defined as clinical research in real-world c...

24.06.2022- Read more

La Comisión Europea abre su consulta pública sobre la revisión de la legislación farmacéutica básica

El 28 de septiembre la Comisión Europea abrió su consulta pública s...

01.10.2021- Read more

Payer involvement is important for a successful EU HTA framework!

The International Association of Mutual Benefit Societies (AIM) welcom...

08.07.2021- Read more

AIM successfully launches its Calculator for Fair Medicines Prices in Europe

The International Association of Mutual Benefit Societies (AIM) has la...

11.06.2021- Read more

Joint Statement – Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy

Ahead of Friday 18 September's webinar the EU Vaccine Strategy, a numb...

21.09.2020- Read more

AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union

AIM, the International Association of Mutual Benefit Societies, has ar...

03.07.2020- Read more

EU Collaboration on Vaccination

The current outbreak of COVID-19, its crippling effects on European ec...

22.04.2020- Read more

European patients need fair medicines prices

The press regularly announces the discovery of a new drug or the purch...

04.12.2019- Read more

Medical Devices: Time to implement Regulations and increase Transparency

AIM, together with the European Association of Hospital Pharmacists (E...

26.02.2019- Read more
1 2 3